Who invested in Arbor Biotechnologies

One round we have observed, with the 7 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Funding summaryUpdated 26 Oct 2026

$74Mraised across 1 round since 2025, from 1 source

Latest round: Series C, $74MMar 2025
Investors: 7

See who backed them

The rounds

Mar 2025
Series C$74M
Source recorded

Founders and team

From Arbor Biotechnologies's own website and the SEC filings it signed: 6 on the team.

Previous NextChief Executive Officer
David ChengExecutive Officeri
Devyn SmithExecutive Officer, Directori
John MurphyExecutive Officeri
Kelly MorganExecutive Officeri
Pam StetkiewiczExecutive Officeri

On the board, as filediChen YuDavid WaltKeith CrandellMark AngelinoPaul MeisterRami Harawi

Everyone who backed them

Temasek HoldingsVC firm1round

ARCH Venture PartnersVC firm1round

Janus Henderson InvestorsPrivate equity1round

TCGPrivate equity1round

GreatPoint VenturesVC firm1round

S32VC firm1round

TCG CrossoverVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Arbor Biotechnologies

Who invested in Arbor Biotechnologies?

Arbor Biotechnologies's investors include Temasek Holdings, ARCH Venture Partners, Janus Henderson Investors, TCG and GreatPoint Ventures, and 2 more on record.

How much has Arbor Biotechnologies raised?

Arbor Biotechnologies has raised $74M across 1 round since 2025.

When did Arbor Biotechnologies last raise?

Arbor Biotechnologies's most recent round was a Series C of $74M in Mar 2025.

What was Arbor Biotechnologies's biggest round?

Its most recent round, $74M in Mar 2025, is also its largest on record.

Who backed Arbor Biotechnologies first?

Arbor Biotechnologies's first round on record, in Mar 2025, was backed by Temasek Holdings, ARCH Venture Partners and Janus Henderson Investors and 4 others.